Norges Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15B | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.14B | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.65B | Buy |
|
|||||
|
2024
Q1 | $1.41B | Sell |
|
|||||
|
2023
Q4 | $1.35B | Buy |
|
|||||
|
2023
Q3 | $1.13B | Buy |
|
|||||
|
2023
Q2 | $1.14B | Buy |
|
|||||
|
2023
Q1 | $1.15B | Buy |
|
|||||
|
2022
Q4 | $1.25B | Buy |
|
|||||
|
2022
Q3 | $1.04B | Buy |
|
|||||
|
2022
Q2 | $1.08B | Sell |
|
|||||
|
2022
Q1 | $1.14B | Sell |
|
|||||
|
2021
Q4 | $1.13B | Sell |
|
|||||
|
2021
Q3 | $923M | Sell |
|
|||||
|
2021
Q2 | $980M | Sell |
|
|||||
|
2021
Q1 | $970M | Buy |
|
|||||
|
2020
Q4 | $867M | Sell |
|
|||||
|
2020
Q3 | $729M | Sell |
|
|||||
|
2020
Q2 | $714M | Buy |
|
|||||
|
2020
Q1 | $568M | Sell |
|
|||||
|
2019
Q4 | $775M | Hold |
|
|||||
|
2019
Q3 | $616M | Hold |
|
|||||
|
2019
Q2 | $724M | Buy |
|
|||||
|
2019
Q1 | $729M | Sell |
|
|||||
|
2018
Q4 | $667M | Buy |
|
|||||
|
2018
Q3 | $676M | Sell |
|
|||||
|
2018
Q2 | $588M | Buy |
|
|||||
|
2018
Q1 | $530M | Sell |
|
|||||
|
2017
Q4 | $574M | Buy |
|
|||||
|
2017
Q3 | $479M | Hold |
|
|||||
|
2017
Q2 | $474M | Sell |
|
|||||
|
2017
Q1 | $425M | Sell |
|
|||||
|
2016
Q4 | $377M | Buy |
|
|||||
|
2016
Q3 | $304M | Hold |
|
|||||
|
2016
Q2 | $334M | Buy |
|
|||||
|
2016
Q1 | $339M | Sell |
|
|||||
|
2015
Q4 | $355M | Buy |
|
|||||
|
2015
Q3 | $340M | Sell |
|
|||||
|
2015
Q2 | $401M | Buy |
|
|||||
|
2015
Q1 | $369M | Buy |
|
|||||
|
2014
Q4 | $289M | Sell |
|
|||||
|
2014
Q3 | $279M | Sell |
|
|||||
|
2014
Q2 | $504M | Buy |
|
|||||
|
2014
Q1 | $233M | Hold |
|
|||||
|
2013
Q4 | $216M | Sell |
|
|||||
|
2013
Q3 | $219M | Hold |
|
|||||
|
2013
Q2 | $215M | Buy |
|